Dayspring Pharma Announces Positive Topline Results From Phase II Clinical Trial Of CG2001 For The Treatment Of Androgenetic Alopecia (AGA)

(MENAFN - PR Newswire) SEOUL, South Korea, June 7, 2026 /PRNewswire/ -- Dayspring Pharma, a clinical-stage biotechnology company focused on innovative dermatology therapies, announced the first ...